Fairmont Banff Springs Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Engineering the Genome  (Q2)

joint with the meeting on Emerging Cellular Therapies: Cancer and Beyond (Q1)

Scientific Organizers: Vic Myer and Erik Sontheimer


February 8—12, 2020

Fairmont Banff Springs, Banff, Alberta, Canada


Supported by the Directors' Fund


BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Oct 8, 2019 [details]
Discounted Abstract Deadline: Oct 8, 2019 [details]
Abstract Deadline: Nov 6, 2019 [details]
Discounted Registration Deadline: Dec 10, 2019 [details]

Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2020-Q2 "Engineering the Genome " conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On October 8, 2019 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After October 8, 2019 until November 6, 2019 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
October 8, 2019 n/a
Discounted NON-STUDENT Registration
More details
Before and On December 10, 2019 945.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After December 10, 2019 1145.00 USD
Discounted STUDENT Registration
More details
Before and On December 10, 2019 720.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After December 10, 2019 920.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.

Apply for a Scholarship



Discounted Abstract Deadline: October 8, 2019

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is November 6, 2019)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: October 8, 2019

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: November 6, 2019

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is October 8, 2019)

Discounted Registration Deadline: December 10, 2019

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 945.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 720.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1145.00 USD*
Student Registration Fee: 920.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Saturday, February 8 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Wednesday, February 12 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Thursday, February 13 in order to fully experience the meeting.

SATURDAY, FEBRUARY 8

16:00—20:00
Arrival and Registration

Van Horne Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Van Horne Foyer

SUNDAY, FEBRUARY 9

07:00—08:00
Breakfast

Mezzanine 2
08:00—09:30
Welcome and Keynote Session (Joint)
Registered attendees can view abstracts starting on 01/08/2020

Van Horne A/B
Carl H. June, University of Pennsylvania, USA
Updates with Engineered T Cells

Jennifer A. Doudna, HHMI/University of California, Berkeley, USA
Biology and Mechanisms of Genome Editing Enzymes

Coffee Break

09:50—12:00
Biochemistry, Biophysics and New Enzymes
Registered attendees can view abstracts starting on 01/08/2020

Van Horne C
Kira S. Makarova, National Center for Biotechnology Information, USA
In silico Discovery of New Defense Systems

Ilya J. Finkelstein, University of Texas at Austin, USA
Massively-Parallel Profiling of Natural and Engineered High-Fidelity CRISPR Nucleases

Yanli Wang, Chinese Academy of Sciences, China
Structure Function of CRISPR Enzymes

Short Talks Chosen from Abstracts

09:50—12:00
Genetically Engineered T Cell Therapies for Cancer: Results from the Clinic
Registered attendees can view abstracts starting on 01/08/2020

Van Horne A/B
Stanley R. Riddell, Fred Hutchinson Cancer Research Center, University of Washington, USA
CAR T Cells for Solid Tumors

Coffee Break

Christine E. Brown, Beckman Research Institute, City of Hope, USA
CAR T Cells for Brain Tumors

Kristen Hege, Celgene, USA
CAR T Cells for Multiple Myeloma

Short Talks Chosen from Abstracts

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

Mezzanine 2
13:00—22:00
Poster Viewing

Mezzanine 2
14:30—16:30
Workshop 1: Ethics of Genome Editing

Van Horne C
Short Talks Chosen from Abstracts

14:30—16:30
Workshop 1: Platforms for Immune Cell Engineering

Van Horne A/B
Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Van Horne Foyer
17:00—19:00
In Vivo Genome Editing
Registered attendees can view abstracts starting on 01/08/2020

Van Horne C
James M. Wilson, University of Pennsylvania, USA
In vivo Editing to Primate Liver

Edward J. Rebar, Sangamo Therapeutics, Inc., USA
Update on Genome Editing in the Liver

David V. Schaffer, University of California, Berkeley, USA
Development of Novel AAV Capsids for in vivo Delivery of Gene Editing Therapies

Short Talks Chosen from Abstracts

17:00—19:00
Engineered Hematopoietic Stem Cells for Treatment of Genetic Diseases
Registered attendees can view abstracts starting on 01/08/2020

Van Horne A/B
Philippe Leboulch, University of Paris-Sud and Harvard University, France
Gene Therapy for Hemoglobinopathies: Challenges to Solve

Marina Cavazzana, Paris Descartes University, France
Gene therapy for Immunodeficiencies

Alessandra Biffi, Dana-Farber Cancer Institute, Boston Children's Hospital, USA
Engineered HSCs for Correction of CNS Disorders

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Mezzanine 2
19:30—22:00
Poster Session 1

Mezzanine 2

MONDAY, FEBRUARY 10

07:00—08:00
Breakfast

Mezzanine 2
08:00—11:00
Genome Editing as a Biology Discovery Tool
Registered attendees can view abstracts starting on 01/08/2020

Van Horne C
Alan Huang, Tango Therapeutics, USA
Novel Combination Therapeutic Approaches Identified by Screening

Kathy K. Niakan, Francis Crick Institute, UK
Towards an Understanding of Human Development Using Gene Ablation

Coffee Break

Philipp Junker, Max Delbrück Center for Molecular Medicine, Germany
Massively Parallel Lineage Tracing Using CRISPR

Birgit C. Schultes, IntelliaTherapeutics, USA
Equipping T Cells for Solid Tumor Therapy – Learnings from CRISPR Screens

Short Talks Chosen from Abstracts

08:00—11:00
Next Generation Immune Cell Engineering
Registered attendees can view abstracts starting on 01/08/2020

Van Horne A/B
Crystal L. Mackall, Stanford University, USA
Engineering Enhanced Potency T Cells

Chiara Bonini, Vita Salute San Raffaele University, Italy
Crispr based Editing of Engineered TCR Therapeutics

Coffee Break

Christopher A. Klebanoff, Memorial Sloan Kettering Cancer Center, USA
Targeting Solid Malignancies with "Public" Neoantigen TCRs

Aude G. Chapuis, Fred Hutchinson Cancer Research Center, USA
Enhancing the Efficacy of eTCR Therapies for Solid Tumors

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Mezzanine 2
13:00—22:00
Poster Viewing

Mezzanine 2
14:30—16:30
Workshop 2: Bacterial Adaptive Immunity Anti CRISPR

Van Horne C
Short Talks Chosen from Abstracts

14:30—16:30
Workshop 2: HSC and iPSC Engineering and Therapy

Van Horne A/B
Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Van Horne Foyer
17:00—19:00
Translational Science of Genome Editing: Assessing Specificity, Immunogenicity and Safety
Registered attendees can view abstracts starting on 01/08/2020

Van Horne C
J. Keith Joung, Massachusetts General Hospital, USA
Advances in Identifying and Modulating the Specificities of Gene Editing Technologies

Zuben E. Sauna, Food and Drug Administration, USA
Prevalence of Pre-Existing Antibodies and T Cell Responses to CRISPR-associated Nuclease Cas9 in the US Population

Speaker to be Announced

Short Talks Chosen from Abstracts

17:00—19:00
Cell Therapy for Infection and Autoimmune Diseases
Registered attendees can view abstracts starting on 01/08/2020

Van Horne A/B
Jeffrey A. Bluestone, University of California, San Francisco, USA
Treg Therapy of Autoimmune Disease

Bruce R. Blazar, University of Minnesota, USA
Treg Therapies in the Setting of Allogeneic HSCT

Hans-Peter Kiem, Fred Hutchinson Cancer Research Center, USA
Engineering Resistance to HIV Infection

Megan K. Levings, University of British Columbia, Canada
Treg Based Therapeutics

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Mezzanine 2
19:30—22:00
Poster Session 2

Mezzanine 2

TUESDAY, FEBRUARY 11

07:00—08:00
Breakfast

Mezzanine 2
08:00—11:00
Crispr Based Editing of Non Immune Cells (Joint)
Registered attendees can view abstracts starting on 01/08/2020

Van Horne A/B
Matthew Porteus, Stanford University School of Medicine, USA
Crispr Editing of Human HSCs

Alex Marson, University of California, San Francisco, USA
Viral Free Crispr Based Gene Transfer

Coffee Break

Jacob E. Corn, ETH in Zurich, Switzerland
High Efficiency HDR in Difficult Cells

Scot A. Wolfe, University of Massachusetts Medical School, USA
Precise Therapeutic Gene Correction by a Simple Nuclease-Induced Double-Strand Break

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Mezzanine 2
13:00—22:00
Poster Viewing

Mezzanine 2
14:30—16:30
Workshop 3: Regulatory Science (Joint)

Van Horne A/B
Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Van Horne Foyer
17:00—19:00
“Off the Shelf” Allogeneic Cell Therapies (Joint)
Registered attendees can view abstracts starting on 01/08/2020

Van Horne A/B
Daniel Shoemaker, Fate Therapeutics, USA
Next Generation iPSC Derived Cell Therapies for Cancer

Jon Terrett, CRISPR Therapeutics, Switzerland
Development of an Allogeneic T Cell Therapy for Oncology

Sonja Schrepfer, University of California San Francisco, USA
Prevention of Immune Rejection of Allogeneic iPSC-Derived Cell Transplants by Genetic Engineering

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Mezzanine 2
19:30—22:00
Poster Session 3

Mezzanine 2

WEDNESDAY, FEBRUARY 12

07:00—08:00
Breakfast

Mezzanine 2
08:00—11:00
DNA Repair and Genome Editing
Registered attendees can view abstracts starting on 01/08/2020

Van Horne C
James E. Haber, Brandeis University, USA
Repair of Broken Chromosomes and Triggering of the DNA Damage Response

Vic E. Myer, Editas Medicine, USA
DNA Repair and Genomic Stability in Primary Human Cells

Coffee Break

Albert B. Seymour, , USA
AAVHSC-Mediated Genome Editing through Homologous Recombination: Applications in Liver-Mediated Diseases

Gaelle Legube, Center for Integrative Biology, France
Chromatin and Chromosome Dynamics at DNA Double Strand Break

Short Talks Chosen from Abstracts

08:00—11:00
Using Synthetic Biology to Enhance Safety and Efficacy of Cellular Therapeutics
Registered attendees can view abstracts starting on 01/08/2020

Van Horne A/B
Yvonne Y. Chen, University of California, Los Angeles, USA
Synthetic Biology to Engineer More Potent CAR T Cells

Kole T. Roybal, University of California, San Francisco, USA
Engineering Next-Generation Immune Cell Therapies for Solid Tumors

Coffee Break

Marius Wernig, Stanford University, USA
IPSC Derived Cells Engineered with CRISPR for Treatment of Epidermolysis Bullosae

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

16:30—17:00
Coffee Available

Van Horne Foyer
17:00—18:45
New Genome Editing Tools
Registered attendees can view abstracts starting on 01/08/2020

Van Horne C
David R. Liu, Broad Institute, HHMI, and Harvard University, USA
Evolution of Base Editing

Erik Sontheimer, University of Massachusetts Medical School, USA
Cas9 Editing Platforms

Yan Zhang, University of Michigan, USA
Long-Range Genome Engineering in Human Embryonic Stem Cells with CRISPR-Cas3

Short Talk Chosen from Abstracts

17:00—18:45
Non-T Immune Cell Therapies
Registered attendees can view abstracts starting on 01/08/2020

Van Horne A/B
Katy Rezvani, University of Texas MD Anderson Cancer Center, USA
NK-CAR T Cells

Jeffrey S. Miller, University of Minnesota, USA
Novel Strategies to Activate and Target NK Cells as Off-The-Shelf Therapy to Treat Cancer

Leonid S. Metelitsa, Baylor College of Medicine, USA
NKT Cells as a Platform for Adoptive Cancer Immunotherapy

Short Talk Chosen from Abstracts

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/08/2020

Van Horne C
18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/08/2020

Van Horne A/B
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Mezzanine 2
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Mezzanine 2

THURSDAY, FEBRUARY 13

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge additional support from these exhibitors at this conference:

10x Genomics BEX CO., LTD.

Cellecta, Inc.

 
Please stop by to meet these exhibitors during the conference.


We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health
National Center for Advancing Translational Sciences (NCATS)
Office of the Director (OD)

Grant No. 1R13TR003025-01

Funding for this conference was made possible (in part) by 1R13TR003025-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. This grant is co-funded by Office Of The Director, National Institutes Of Health (OD)


We gratefully acknowledge additional support for this conference from:

Intellia Therapeutics

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Corporate Relations, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org,
Phone:+1 970-262-1179